MUTZ-3-derived dendritic cells as an in vitro alternative model to CD34+ progenitor-derived dendritic cells for testing of chemical sensitizers

Toxicology in Vitro

Volumn 23, Issue 8, 2009, Pages 1477-1481

  Nelissen, Inge ^a   Selderslaghs, Ingrid ^a   Heuvel, Rosette Van Den ^a   Witters, Hilda ^a   Verheyen, Geert R ^a   Schoeters, Greet ^a  

^a FLEMISH INSTITUTE FOR TECHNOLOGICAL RESEARCH VITO   (Belgium)

Author keywords

Dendritic cell; MUTZ 3; Skin sensitization

Indexed keywords

CD34 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CHEMOKINE; CHEMOKINE CCL3L1; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NICKEL SULFATE; UNCLASSIFIED DRUG;

ALLERGY TEST; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL STIMULATION; CELL STRAIN MUTZ 3; CELL STRUCTURE; CHEMOSENSITIVITY; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EXPERIMENTAL MODEL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; VALIDATION PROCESS;

ANTIGENS, CD34; CELL LINE, TUMOR; CYTOKINES; DENDRITIC CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; NICKEL; PHENOTYPE;

EID: 70449535867     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2009.08.022     Document Type: Article

References (23)

1. Aiba S., Terunuma A., Manome H., and Tagami H. Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Eur. J. Immunol. 27 (1997) 3031-3038
2. Azam P., Peiffer J.-L., Chamousset D., Tissier M.-H., Bonnet P.-A., Vian L., Fabre I., and Ourlin J.-C. The cytokine-dependent MUTZ-3 cell line as an in vitro model for the screening of contact sensitizers. Toxicol. Appl. Pharmacol. 212 (2006) 14-23
3. Berges C., Naujokat C., Tinapp S., Wieczorek H., Hoh A., Sadeghi M., Opelz G., and Daniel V. A cell line model for the differentiation of human dendritic cells. Biochem. Biophys. Res. Commun. 333 (2005) 896-907
4. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF + TNF-alpha. J. Exp. Med. 184 (1996) 695-706
5. + regulatory T (Treg) cells: a comparative study of naïve and antigenic-specific cord blood Treg cells. Exp. Hematol. 33 (2005) 1508-1520
6. +-derived DC by NiCl(2) and SDS. Toxicol. In Vitro 15 (2001) 319-325
7. + progenitor-derived dendritic cells to distinguish between sensitizers and irritants. Toxicol. Lett. 156 (2005) 377-389
8. Hooyberghs J., Schoeters E., Lambrechts N., Nelissen I., Witters H., Schoeters G., and Van Den Heuvel R. A cell-based in vitro alternative to identify skin sensitizers by gene expression. Toxicol. Appl. Pharmacol. 231 (2008) 103-111
9. Hulette B.A., Ryan C.A., and Gerberick G.F. Elucidating changes in surface marker expression of dendritic cells following chemical allergen treatment. Toxicol. Appl. Pharmacol. 182 (2002) 226-233
10. Hulette B.C., Ryan C.A., Gildea L.A., and Gerberick G.F. Relationship of CD86 surface marker expression and cytotoxicity on dendritic cells exposed to chemical allergen. Toxicol. Appl. Pharmacol. 209 (2005) 159-166
11. Kim K.D., Choi S.-C., Noh Y.-W., Kim J.W., Paik S.-G., Yang Y., Kim K.I.I., and Lim J.-S. Impaired responses of leukemic dendritic cells derived from a human myeloid cell line to LPS stimulation. Exp. Mol. Med. 38 (2006) 72-84
12. Lardon F., Snoeck H.-W., Berneman Z.N., Van Tendeloo V.F.I., Nijs G., Lenjou M., Henckaerts E., Boeckxstaens C.J., Vandenabeele P., Kestens L.L., and Van Bockstaele D.R. Generation of dendritic cells from bone marrow progenitors using GM-CSF, TNF-alpha and additional cytokines: antagonistic effects of IL-4 and IFN-gamma and selective involvement of TNF-alpha receptor-1. Immunology 91 (1997) 553-559
13. Larsson K., Lindstedt M., and Borrebaeck C.A.K. Functional and transcriptional profiling of MUTZ-3, a myeloid cell line acting as a model for dendritic cells. Immunology 117 (2006) 156-166
14. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25 (2001) 402-408
15. + precursors. Blood 100 (2002) 701-703
16. Rasaiyaah J., Yong K., Katz D.R., Kellam P., and Chain B.M. Dendritic cells and myeloid leukaemias: plasticity and commitment in cell differentiation. Br. J. Haematol. 138 (2007) 281-290
17. + Langerhans cell precursor. J. Leukoc. Biol. 80 (2006) 1337-1344
18. Santegoets S.J.A.M., van den Eertwegh A.J.M., van de Loosdrecht A.A., Scheper R.J., and de Gruijl T.D. Human dendritic cell line models for DC differentiation and clinical DC vaccination studies. J. Leukoc. Biol. 84 (2008) 1364-1373
19. +-progenitor derived dendritic cells exposed to the chemical contact allergen nickel sulfate. Toxicol. Appl. Pharmacol. 216 (2006) 131-149
20. Schoeters E., Verheyen G.R., Nelissen I., Van Rompay A.R., Hooyberghs J., Van Den Heuvel R.L., Witters H., Schoeters G.E., Van Tendeloo V.F., and Berneman Z.N. Microarray analysis in dendritic cells reveal potential biomarkers for chemical-induced skin sensitization. Mol. Immunol. 44 (2007) 3222-3233
21. Tuschl H., Kovac R., and Weber E. The expression of surface markers on dendritic cells as indicators for the sensitizing potential of chemicals. Toxicol. In Vitro 14 (2000) 541-549
22. +-progenitor derived dendritic cells exposed to contact allergens and irritants. Toxicol. Lett. 155 (2005) 187-194
23. Yoshida Y., Sakaguchi H., Ito Y., Okuda M., and Suzuki H. Evaluation of the skin sensitization potential of chemicals using expression of co-stimulatory molecules, CD54 and CD86, on the naïve THP-1 cell line. Toxicol. In Vitro 17 (2003) 221-228